John P. Thomson

3.4k citations

37 papers · 2.0k indexed · 1 hit paper · h-index 21

Molecular Biology top 5%
Surgery top 10%
Genetics top 10%
Hepatology top 5%
Cancer Research top 10%

Co-authors: Richard R. Meehan Peter J. Skene Robert S. Illingworth Shaun Webb Alastair Kerr Jonathan G. Moggs Adrian Bird Jacky Guy
Topics: Epigenetics and DNA Methylation (21 papers)RNA modifications and cancer (9 papers)Ovarian cancer diagnosis and treatment (7 papers)
Cited by: Hepatology Aging Molecular Biology
Journals: Nature Nucleic Acids Research Nature Communications
Partner nations: United Kingdom Switzerland Germany

In The Last Decade

John P. Thomson

35 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration

2017 381 citations Eoghan O’Duibhir, John P. Thomson et al. profile →

Peers

Countries citing papers authored by John P. Thomson

Since Specialization

Citations

This map shows the geographic impact of John P. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Thomson more than expected).

Fields of papers citing papers by John P. Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Thomson. The network helps show where John P. Thomson may publish in the future.

Co-authorship network of co-authors of John P. Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Thomson. A scholar is included among the top collaborators of John P. Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Thomson. John P. Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animals 2025 ·Archives of Toxicology ·Colin J. Henderson,Aileen McLaren,Andrew K. MacLeod,De‐Chen Lin,Amy Cameron,(unknown),Jonathan G. Moggs,Francisco Iñesta-Vaquera,John P. Thomson,Richard R. Meehan,Probir Chakravarty,Michael Schwarz,C. Roland Wolf	1
2	Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma 2025 ·Molecular Oncology ·(unknown),Mary K. Danks,John P. Thomson,Morwenna Muir,Martin Lee,John C. Dawson,Ana Teresa Amaral,Juan Díaz‐Martín,David S. Moura,Javier Martín‐Broto,(unknown),Donald M. Salter,(unknown),Graeme R. Grimes,Larry Hayward,Ted R. Hupp,Karen Sisley,Paul H. Huang,Neil O. Carragher,Valerie G. Brunton	0
3	Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome 2023 ·Gynecologic Oncology ·John P. Thomson,Robert L. Hollis,(unknown),(unknown),Michael Churchman,Koen Van de Vijver,Frederike Dijk,Alison Meynert,Clare Bartos,Tzyvia Rye,Ian Croy,(unknown),(unknown),(unknown),(unknown),Fiona Nussey,Christianne Lok,C. Simon Herrington,Charlie Gourley	8
4	Identifying and overcoming a mechanism of resistance to WEE1 kinase inhibitor AZD1775 in high grade serous ovarian cancer cells 2022 ·European Journal of Gynaecological Oncology ·(unknown),John P. Thomson,Graeme R. Grimes,Anderson T. Wang,Michael Churchman,Mark J. O’Connor,Charlie Gourley,David W. Melton	11
5	Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer 2022 ·European Journal of Surgical Oncology ·(unknown),Martyna Adamowicz,John P. Thomson,(unknown),Christelle Robert,(unknown),(unknown),Kate Cuschieri,(unknown),Brendan Conn,Ashley Hay,Iain J. Nixon,Timothy J. Aitman	22
6	Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification 2021 ·npj Precision Oncology ·Robert L. Hollis,Bárbara Stanley,John P. Thomson,Michael Churchman,Ian Croy,Tzyvia Rye,Clare Bartos,Fiona Nussey,Melanie Mackean,Alison Meynert,Colin A. Semple,Charlie Gourley,C. Simon Herrington	16
7	A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis 2020 ·iScience ·Matthew C. Sinton,Jose Meseguer-Ripolles,Baltasar Lucendo‐Villarin,(unknown),John P. Thomson,Roderick N. Carter,Marcus J. Lyall,Paul D. Walker,Alpesh Thakker,Richard R. Meehan,Gareth G. Lavery,Nicholas M. Morton,Christian Ludwig,Daniel A. Tennant,David C. Hay,Amanda J. Drake	20
8	Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome 2020 ·Nature Communications ·Robert L. Hollis,John P. Thomson,Bárbara Stanley,Michael Churchman,Alison Meynert,Tzyvia Rye,Clare Bartos,Yasushi Iida,Ian Croy,Melanie Mackean,Fiona Nussey,Aikou Okamoto,Colin A. Semple,Charlie Gourley,C. Simon Herrington	83
9	DNA Methylation Directs Polycomb-Dependent 3D Genome Re-organization in Naive Pluripotency 2019 ·Cell Reports ·(unknown),Ilya M. Flyamer,John P. Thomson,Heidi K. Mjoseng,Ruchi Shukla,Iain Williamson,Graeme R. Grimes,Robert S. Illingworth,Ian R. Adams,Sari Pennings,Richard R. Meehan,Wendy A. Bickmore	62
10	Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma 2019 ·Gynecologic Oncology ·Robert L. Hollis,Bárbara Stanley,Yasushi Iida,John P. Thomson,Michael Churchman,Tzyvia Rye,Melanie Mackean,Fiona Nussey,Charlie Gourley,C. Simon Herrington	22
11	Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells 2018 ·Philosophical Transactions of the Royal Society B Biological Sciences ·Marcus J. Lyall,Jessy Cartier,John P. Thomson,Kate Cameron,Jose Meseguer-Ripolles,Eoghan O’Duibhir,Dagmara Szkolnicka,Baltasar Lucendo‐Villarin,Yu Wang,Giovanny Rodriguez Blanco,Warwick B. Dunn,Richard R. Meehan,David C. Hay,Amanda J. Drake	30
12	DNA methylation as a genomic marker of exposure to chemical and environmental agents 2018 ·Current Opinion in Chemical Biology ·Richard R. Meehan,John P. Thomson,Antonio Lentini,Colm E. Nestor,Sari Pennings	47
13	Investigation into the role of the germline epigenome in the transmission of glucocorticoid-programmed effects across generations 2018 ·Genome biology ·Jessy Cartier,Tom Smith,John P. Thomson,(unknown),Batbayar Khulan,Andreas Heger,Richard R. Meehan,Amanda J. Drake	18
14	Diverse interventions that extend mouse lifespan suppress shared age-associated epigenetic changes at critical gene regulatory regions 2017 ·Genome biology ·John Cole,Neil Robertson,(unknown),John P. Thomson,Tony McBryan,Duncan Sproul,Tina Wang,(unknown),William Clark,Trey Ideker,Richard R. Meehan,Richard A. Miller,Holly M. Brown‐Borg,Peter D. Adams	130
15	Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver Cancer 2016 ·Cancer Research ·John P. Thomson,Raffaele Ottaviano,(unknown),Harri Lempiäinen,Arne Müller,Rémi Terranova,Robert S. Illingworth,Shaun Webb,Alastair Kerr,Marcus J. Lyall,Amanda J. Drake,C. Roland Wolf,Jonathan G. Moggs,Michael Schwarz,Richard R. Meehan	69
16	5-Hydroxymethylcytosine Profiling in Human DNA 2015 ·Methods in molecular biology ·John P. Thomson,Colm E. Nestor,Richard R. Meehan	4
17	Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems 2015 ·Genome biology ·Colm E. Nestor,Raffaele Ottaviano,Diana Reinhardt,Hazel A. Cruickshanks,Heidi K. Mjoseng,Rhoanne C. McPherson,Antonio Lentini,John P. Thomson,Donncha S. Dunican,Sari Pennings,Stephen M. Anderton,Mikael Benson,Richard R. Meehan	129
18	DNA immunoprecipitation semiconductor sequencing (DIP-SC-seq) as a rapid method to generate genome wide epigenetic signatures 2015 ·Scientific Reports ·John P. Thomson,Angie Fawkes,Raffaele Ottaviano,Jennifer M. Hunter,Ruchi Shukla,Heidi K. Mjoseng,Richard Clark,(unknown),Lee Murphy,Richard R. Meehan	14
19	Epigenetic profiles as defined signatures of xenobiotic exposure 2013 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·John P. Thomson,Jonathan G. Moggs,C. Roland Wolf,Richard R. Meehan	47
20	Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver 2013 ·Nucleic Acids Research ·John P. Thomson,Jennifer M. Hunter,Harri Lempiäinen,Arne Müller,Rémi Terranova,Jonathan G. Moggs,Richard R. Meehan	72

About John P. Thomson

John P. Thomson is a scholar working on Reproductive Medicine, Aging and Obstetrics and Gynecology, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (21 papers), RNA modifications and cancer (9 papers) and Ovarian cancer diagnosis and treatment (7 papers). The work is most often cited by research in Hepatology (279 citations), Aging (43 citations) and Molecular Biology (1.4k citations). John P. Thomson has collaborated with scholars based in United Kingdom, Switzerland and Germany. Frequent co-authors include Richard R. Meehan, Peter J. Skene, Robert S. Illingworth, Shaun Webb, Alastair Kerr, Jonathan G. Moggs, Adrian Bird, Jacky Guy, Keith James and Robert Andrews. Their work appears in journals such as Nature, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact